文献速递艾滋病与性传播感染

HIV-1整合酶编码区插入突变的首次特征分析

First characterization of insertions in the HIV-1 integrase-coding region from people with HIV.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

本研究对13例HIV-1感染者整合酶编码序列中的插入突变进行特征分析,首次记录到第168、253、255和260位氨基酸插入。病毒学与生化实验及三维建模显示,这些插入突变降低逆转录效率、延缓病毒复制,但未对拉替拉韦和度鲁特韦产生耐药。

要点

  • 首次记录HIV-1整合酶第168、253、255和260位氨基酸插入。
  • 插入突变降低逆转录效率并延缓病毒复制。
  • 插入突变未导致对拉替拉韦或度鲁特韦耐药。

核心结论

  • HIV-1感染者整合酶编码区的插入突变不赋予对整合酶抑制剂耐药,但损害病毒复制。

研究设计与样本

  • 对13例HIV-1感染者整合酶编码序列中的插入突变进行分析,采用病毒学、生化实验及三维建模。

主要发现

  • 首次记录到整合酶第168、253、255和260位氨基酸插入。
  • 定量PCR分析显示插入突变降低逆转录效率,并对病毒整合产生不同影响。
  • 突变体病毒复制延迟。
  • 使用拉替拉韦和度鲁特韦的病毒学实验未观察到耐药。

临床怎么用

  • 临床解读整合酶插入突变时,不应仅凭插入突变判定对整合酶抑制剂耐药。

局限性

  • 仅基于13例HIV-1感染者,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to gain a better understanding of the role of insertional mutations in the integrase (IN)-coding sequence of 13 HIV-1-infected people. RESULTS: Here, we present the first documentation of amino acid insertion in the IN-coding sequence of HIV-1-infected people at positions 168, 253, 255 and 260. The consequences of these mutations in terms of viral replication and resistance to INSTIs were analysed using virological and biochemical assays and 3D modelling. Analysis of viral genomes by quantitative PCR demonstrated that insertional mutations reduce reverse transcription efficiency and had different impacts on viral integration. Taken together, we showed that mutants were delayed in their replication. Virological assays using two potent strand-transfer inhibitors (INSTIs), raltegravir and dolutegravir, demonstrated that no resistance to INSTIs was observed. CONCLUSIONS: Our study has revealed that the mutations observed in people living with HIV-1 do not confer resistance to anti-integrase compounds but are detrimental to viral replication.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Tu NQ, Montrouge T, Mbemba G, et al. First characterization of insertions in the HIV-1 integrase-coding region from people with HIV. J Antimicrob Chemother. 2026. PMID: 41603427. doi:10.1093/jac/dkaf491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。